Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach

• Κύριοι συγγραφείς: Sivakumar Gangadharan (Συγγραφέας), Jenifer Mallavarpu Ambrose (Συγγραφέας), Anusha Rajajagadeesan (Συγγραφέας), Malathi Kullappan (Συγγραφέας), Shankargouda Patil (Συγγραφέας), Sri Harshini Gandhamaneni (Συγγραφέας), Vishnu Priya Veeraraghavan (Συγγραφέας), Aruna Kumari Nakkella (Συγγραφέας), Alok Agarwal (Συγγραφέας), Selvaraj Jayaraman (Συγγραφέας), Krishna Mohan Surapaneni (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Elsevier, 2022-11-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

The high incidences of COVID-19 cases are believed to be associated with high transmissibility rates, which emphasizes the need for the discovery of evidence-based antiviral therapies for curing the disease. The rationale of repurposing existing classes of antiviral small molecule therapeutics again...